Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

This study has been withdrawn prior to enrollment.

Sponsor:

Information provided by (Responsible Party):

Eleos, Inc.

ClinicalTrials.gov Identifier:

NCT00967512

First received: August 26, 2009

Last updated: October 13, 2011

Last verified: October 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2014 (Final data collection date for primary outcome measure)